
Onco-Innovations Integrates Targeted Therapy, Nanotechnology, and AI in Cancer Drug Development
Onco-Innovations is advancing a multifaceted approach combining PNKP-targeted DDR inhibition, nanoparticle delivery, and AI to improve cancer treatment, with lead candidate ONC010 progressing toward clinical trials.
Read full story
























